Targeted Therapy Market Grows as Precision Oncology Gains Momentum
Market insights predict, the targeted therapy industry is expected to grow from USD 85.69 billion in 2025 to USD 166.53 billion by 2035, driven by a CAGR of 6.87%. In 2024, North America led the targeted therapy market (32%), with Asia Pacific set for the fastest growth. Monoclonal antibodies dominated, while small molecules are expected to grow rapidly. Lung cancer was the top application, but breast cancer is the fastest-growing. Hospital pharmacies led, while online pharmacies are surging. Key players include Pfizer, AstraZeneca, Amgen, Roche, and Gilead.
Last Updated : 16 January 2026
Category: Therapeutic Area
Insight Code: 5500
Format: PDF / PPT / Excel